Vnitr Lek 2015, 61(3):209-218

The most recent aspects of diagnosis and therapy of hyponatraemia

Igor Šturdík*, Monika Adamcová, Juraj Payer
V. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta prof. MUDr. Juraj Payer, PhD., FRCP

Hyponatraemia is the most common electrolyte disbalance in clinical practice, which is associated with increased patients morbidity and mortality. At present the pathophysiology of hyponatraemia is explored in more details, antidiuretic hormone and osmoregulation play the major roles. This article informs about relatively new classification of hyponatraemia for clinical practice based on the severity of clinical symptoms and based on the effective serum osmolality. It also offers diagnostic and treatment guidelines of hyponatraemia, which are based on current recommendations of the world experts and on the evidence based medicine.

Keywords: diagnosis; hyponatraemia; pathophysiology; treatment

Received: November 30, 2014; Accepted: January 15, 2015; Published: March 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šturdík I, Adamcová M, Payer J. The most recent aspects of diagnosis and therapy of hyponatraemia. Vnitr Lek. 2015;61(3):209-218.
Download citation

References

  1. Whelan B, Bennett K, O'Riordan D et al. Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM 2009; 102(3): 175-182. Go to original source... Go to PubMed...
  2. Sturdik I, Adamcova M, Kollerova J et al. Hyponatraemia is an independent predictor of in-hospital mortality. Eur J Intern Med 2014; 25(4): 379-382. Go to original source... Go to PubMed...
  3. Rudnay M, Lazurova I. Prevalence of hyponatremia in patients on department of internal medicine. Vnitř Lék 2013; 59(19): 876-879.
  4. Verbalis JG, Goldsmith SR, Greenberg A et al. Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations. Am J Med 2013; 126(10 Suppl 1): S1-S42. Go to original source... Go to PubMed...
  5. Serste T, Gustot T, Rautou PE et al. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol 2012; 57(2): 274-280. Go to original source... Go to PubMed...
  6. Wald R, Jaber BL, Price LL et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010; 170(3): 294-302. Go to original source... Go to PubMed...
  7. Cardenas A, Gines P. Management of patients with cirrhosis awaiting liver transplantation. Gut 2011; 60(3): 412-421. Go to original source... Go to PubMed...
  8. Chawla A, Sterns RH, Nigwekar SU et al. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol 2011; 6(5): 960-965. Go to original source... Go to PubMed...
  9. Baran D, Hutchinson TA. The outcome of hyponatremia in a general hospital population. Clin Nephrol 1984; 22(2): 72-76. Go to PubMed...
  10. Saeed BO, Beaumont D, Handley GH et al. Severe hyponatraemia: investigation and management in a district general hospital. J Clin Pathol 2002; 55(12): 893-896. Go to original source... Go to PubMed...
  11. Spasovski G, Vanholder R, Allolio B et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170(3): G1-G47. Go to original source... Go to PubMed...
  12. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 2003; 17(4): 471-503. Go to original source... Go to PubMed...
  13. Bourque CW. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 2008; 9(7): 519-531. Go to original source... Go to PubMed...
  14. Lechner SG, Markworth S, Poole K et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 2011; 69(2): 332-344. Go to original source... Go to PubMed...
  15. Sharif Naeini R, Witty MF, Seguela P et al. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 2006; 9(1): 93-98. Go to original source... Go to PubMed...
  16. Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 2006; 26(35): 9069-9075. Go to original source... Go to PubMed...
  17. Norsk P. Influence of low- and high-pressure baroreflexes on vasopressin release in humans. Acta Endocrinol (Copenh) 1989; 121(Suppl 1): 3-27. Go to original source... Go to PubMed...
  18. Robertson GL. Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 1983; 101(3): 351-371.
  19. Zhang Z, Bourque CW. Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons. J Neurosci; 28(38): 9536-9544. Go to PubMed...
  20. Schwartz WB, Bennett W, Curelop S et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957; 23(4): 529-542. Go to original source... Go to PubMed...
  21. Turchin A, Seifter JL, Seely EW. Clinical problem-solving. Mind the gap. N Engl J Med 2003; 349(15): 1465-1469. Go to original source... Go to PubMed...
  22. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106(4): 399-403. Go to original source... Go to PubMed...
  23. Desmond J. Serum osmolality and plasma electrolytes in patients who develop dilutional hyponatremia during transurethral resection. Can J Surg 1970; 13(2): 116-121.
  24. Aviram A, Pfau A, Czaczkes JW et al. Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med 1967; 42(4): 648-650. Go to original source... Go to PubMed...
  25. Carlotti AP, Bohn D, Mallie JP et al. Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia. Intensive Care Med 2001; 27(5): 921-924. Go to original source... Go to PubMed...
  26. Hoorn EJ, Carlotti AP, Costa LA et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr 2007; 150(5): 467-473. Go to original source... Go to PubMed...
  27. Friedman E, Shadel M, Halkin H et al. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 1989; 110(1): 24-30. Go to original source... Go to PubMed...
  28. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993; 103(2): 601-606. Go to original source... Go to PubMed...
  29. Sherlock M, O'Sullivan E, Agha A et al. Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J 2009; 85(1002): 171-175. Go to original source... Go to PubMed...
  30. Hamdi T, Latta S, Jallad B et al. Cisplatin-induced renal salt wasting syndrome. South Med J 2010; 103(8): 793-799. Go to original source... Go to PubMed...
  31. Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med 2006; 119(7 Suppl 1): S21-S29. Go to original source... Go to PubMed...
  32. Dedinska I, Manka V, Sagova I et al. Hyponatremia - carbamazepine medication complications. Vnitř Lék 2012; 58(1): 72-75. Go to PubMed...
  33. Tian W, Fu Y, Garcia-Elias A et al. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci USA 2009; 106(33): 14034-14039. Go to original source... Go to PubMed...
  34. Faustini-Fustini M, Anagni M. Beyond semantics: defining hyponatremia in secondary adrenal insufficiency. J Endocrinol Invest 2006; 29(3): 267-269. Go to original source... Go to PubMed...
  35. Warner MH, Holding S, Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol (Oxf) 2006; 64(5): 598-599. Go to original source... Go to PubMed...
  36. Musch W, Xhaet O, Decaux G. Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers. QJM 2003; 96(6): 421-426. Go to original source... Go to PubMed...
  37. Goldberg A, Hammerman H, Petcherski S et al. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 2006; 166(7): 781-786. Go to original source... Go to PubMed...
  38. Goland S, Naugolny V, Korbut Z et al. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic. Eur J Intern Med 2011; 22(4): 424-427. Go to original source... Go to PubMed...
  39. Jiskra J. Hyponatremie: diagnostický postup a nové léčebné možnosti. Hyponatremia: diagnostic process and new therapeutic approaches. Interní Med 2012; 14(8 a 9): 312-317.
  40. Renneboog B, Musch W, Vandemergel X et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119(1): 71. e1-e8. Go to original source... Go to PubMed...
  41. Hoorn EJ, Halperin ML, Zietse R. Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM; 2005; 98(7): 529-540. Go to original source... Go to PubMed...
  42. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 1988; 319(16): 1065-1072. Go to original source... Go to PubMed...
  43. Fenske W, Stork S, Koschker AC et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008; 93(8): 2991-2997. Go to original source... Go to PubMed...
  44. Rozen-Zvi B, Yahav D, Gheorghiade M et al. Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am J Kidney Dis 2010; 56(2): 325-337. Go to original source... Go to PubMed...
  45. Jaber BL, Almarzouqi L, Borgi L et al. Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia. Am J Med 2011; 124(10): 977. e1-e9. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2011.04.028>. Go to original source... Go to PubMed...
  46. De Troyer A. Demeclocycline. Treatment for syndrome of inappropriate antidiuretic hormone secretion. JAMA 1977; 237(25): 2723-2726. Go to original source... Go to PubMed...
  47. Carrilho F, Bosch J, Arroyo V et al. Renal failure associated with demeclocycline in cirrhosis. Ann Intern Med 1977; 87(2): 195-197. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.